Merck
MRK
#42
Rank
C$513.90 B
Marketcap
C$208.30
Share price
2.56%
Change (1 day)
71.97%
Change (1 year)

EPS for Merck (MRK)

EPS in 2026 (TTM): C$1.72

According to Merck's latest financial reports the company's current EPS (TTM) is C$1.81. In 2025 the company made an earnings per share (EPS) of C$10.43 an increase over its 2024 EPS that were of C$9.64.

EPS history for Merck from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$1.72-83.48%
2025C$10.438.15%
2024C$9.644308.46%
2023C$0.22-97.32%
2022C$8.1710.92%
2021C$7.3784.68%
2020C$3.99-27.2%
2019C$5.4863.44%
2018C$3.35151.11%
2017C$1.34-54.58%
2016C$2.9430.21%
2015C$2.26-61.99%
2014C$5.94180.51%
2013C$2.12-31.82%
2012C$3.116.62%
2011C$2.91

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$12.46 590.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$9.50 426.26%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$1.08-39.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$4.45 146.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$42.63 2,261.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$23.14 1,181.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$2.71 50.37%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
C$6.48 258.74%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$4.56 152.67%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
C$0.90-50.22%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel